3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Terminated
1
Sponsor Class
INDUSTRY
2
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Other hematologic neoplasm
1
Myeloid
1
Lymphoid
1
Conditions
Precursor Cell Lymphoblastic Leukemia-Lymphoma
2
Myelodysplastic Syndromes
2
Myeloproliferative Disorders
1
Lymphoma
1
Leukemia, Myelomonocytic, Juvenile
1
Leukemia, Myelomonocytic, Chronic
1
Leukemia, Myelomonocytic, Acute
1
Leukemia, Myeloid, Acute
1
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
1
Leukemia, Biphenotypic, Acute
1
Graft vs Host Disease
1
Interventions
Cyclophosphamide
54
Tacrolimus
50
Methotrexate
36
Mycophenolic Acid
34
fludarabine phosphate
33
Busulfan
31
Cyclosporine
29
fludarabine
28
Antilymphocyte Serum
28
Melphalan
23
Sirolimus
21
Whole-Body Irradiation
18
Radiotherapy
18
Peripheral Blood Stem Cell Transplantation
18
Methylprednisolone
18
Filgrastim
15
thymoglobulin
13
Thiotepa
10
Stem Cell Transplantation
9
Rituximab
9
Granulocyte Colony-Stimulating Factor
8
Hematopoietic Stem Cell Transplantation
7
Etoposide
7
Cord Blood Stem Cell Transplantation
7
Cytarabine
6
Alemtuzumab
6
ruxolitinib
5
Transplantation
5
Therapeutics
5
Prednisone
5
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER
×
Graft vs Host Disease
×
Calcineurin Inhibitors
×
Clear all
NCT01749111
2017-03-03
CICLODECH
Hospital Israelita Albert Einstein
Phase 3
Terminated
3 enrolled